[HTML][HTML] Cytokine-defined B cell responses as therapeutic targets in multiple sclerosis

R Li, A Rezk, LM Healy, G Muirhead, A Prat… - Frontiers in …, 2016 - frontiersin.org
Important antibody-independent pathogenic roles of B cells are emerging in autoimmune
diseases, including multiple sclerosis (MS). The contrasting results of different treatments …

Cytokine-Defined B Cell Responses as Therapeutic Targets in Multiple Sclerosis.

R Li, A Rezk, LM Healy, G Muirhead, A Prat… - Frontiers in …, 2016 - europepmc.org
Important antibody-independent pathogenic roles of B cells are emerging in autoimmune
diseases, including multiple sclerosis (MS). The contrasting results of different treatments …

Cytokine-Defined B Cell Responses as Therapeutic Targets in Multiple Sclerosis

R Li, A Rezk, LM Healy, G Muirhead, A Prat… - 2016 - escholarship.mcgill.ca
Important antibody-independent pathogenic roles of B cells are emerging in autoimmune
diseases, including multiple sclerosis (MS). The contrasting results of different treatments …

[PDF][PDF] Cytokine-Defined B Cell Responses as Therapeutic Targets in Multiple Sclerosis

R Li, A Rezk, LM Healy, G Muirhead, A Prat - Frontiers in Immunology, 2016 - core.ac.uk
Important antibody-independent pathogenic roles of B cells are emerging in autoimmune
diseases, including multiple sclerosis (MS). The contrasting results of different treatments …

[HTML][HTML] Cytokine-Defined B Cell Responses as Therapeutic Targets in Multiple Sclerosis

R Li, A Rezk, LM Healy, G Muirhead, A Prat… - Frontiers in …, 2015 - ncbi.nlm.nih.gov
Important antibody-independent pathogenic roles of B cells are emerging in autoimmune
diseases, including multiple sclerosis (MS). The contrasting results of different treatments …

[HTML][HTML] Cytokine-Defined B Cell Responses as Therapeutic Targets in Multiple Sclerosis

R Li, A Rezk, LM Healy, JL Gommerman… - Frontiers in …, 2016 - frontiersin.org
Important antibody-independent pathogenic roles of B cells are emerging in autoimmune
diseases, including multiple sclerosis (MS). The contrasting results of different treatments …

[引用][C] Cytokine-Defined B Cell Responses as Therapeutic Targets in Multiple Sclerosis

R Li, A Rezk, LM Healy, G Muirhead, A Prat… - Frontiers in …, 2016 - cir.nii.ac.jp

[PDF][PDF] Cytokine-Defined B Cell Responses as Therapeutic Targets in Multiple Sclerosis

R Li, A Rezk, LM Healy, G Muirhead… - Frontiers in …, 2016 - researchgate.net
Important antibody-independent pathogenic roles of B cells are emerging in autoimmune
diseases, including multiple sclerosis (MS). The contrasting results of different treatments …

Cytokine-Defined B Cell Responses as Therapeutic Targets in Multiple Sclerosis

R Li, A Rezk, LM Healy, G Muirhead… - Frontiers in …, 2016 - pubmed.ncbi.nlm.nih.gov
Important antibody-independent pathogenic roles of B cells are emerging in autoimmune
diseases, including multiple sclerosis (MS). The contrasting results of different treatments …

Cytokine-Defined B Cell Responses as Therapeutic Targets in Multiple Sclerosis.

R Li, A Rezk, LM Healy, G Muirhead, A Prat… - Frontiers in …, 2016 - europepmc.org
Important antibody-independent pathogenic roles of B cells are emerging in autoimmune
diseases, including multiple sclerosis (MS). The contrasting results of different treatments …